Risk stratification for cancer-associated venous thromboembolism
GC Connolly, AA Khorana - Best Practice & Research Clinical …, 2009 - Elsevier
The risk of venous thromboembolism (VTE) is elevated in cancer, and thrombosis is the
second leading cause of death in patients with malignancy. Many risk factors for cancer …
second leading cause of death in patients with malignancy. Many risk factors for cancer …
Risk stratification for cancer-associated venous thromboembolism.
GC Connolly, AA Khorana - Best Practice & research. Clinical …, 2009 - europepmc.org
The risk of venous thromboembolism (VTE) is elevated in cancer, and thrombosis is the
second leading cause of death in patients with malignancy. Many risk factors for cancer …
second leading cause of death in patients with malignancy. Many risk factors for cancer …
Risk stratification for cancer-associated venous thromboembolism
GC Connolly, AA Khorana - Best Practice & Research Clinical …, 2009 - infona.pl
The risk of venous thromboembolism (VTE) is elevated in cancer, and thrombosis is the
second leading cause of death in patients with malignancy. Many risk factors for cancer …
second leading cause of death in patients with malignancy. Many risk factors for cancer …
Risk stratification for cancer-associated venous thromboembolism
GC Connolly, AA Khorana - Best practice & research …, 2009 - pubmed.ncbi.nlm.nih.gov
The risk of venous thromboembolism (VTE) is elevated in cancer, and thrombosis is the
second leading cause of death in patients with malignancy. Many risk factors for cancer …
second leading cause of death in patients with malignancy. Many risk factors for cancer …